Drugs / Cortancyl
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy2 trials | ||||||
| Phase 3 | NCT03323476 Comparator | Feb 2018 → Mar 2028 expected | anti-neutrophil cytoplasmic antibody-associated vasculitis, end stage renal failure | Centre Hospitalier Departemental Vendee | Active not recruiting | No outcome recorded |
| Phase 4 | NCT00545402 Comparator | Nov 2007 → Jul 2011 | — | Hoffmann-La Roche | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Cortancyl | “Cortancyl” NCT00545402 ↗ |